TherapeuticsMD Inc. | Mutual Funds
Mutual Funds that own TherapeuticsMD Inc.
T Rowe Price Small Cap Stock Fund
6,737,603
3.11%
2,094,600
0.42%
06/30/2018
Dreyfus Opportunistic Small Cap Fund
6,362,409
2.94%
0
3.28%
04/30/2018
JPMorgan Growth Advantage Fund
6,047,278
2.79%
0
0.41%
07/31/2018
FTIF SICAV - Franklin Biotechnology Discovery Fund
4,663,436
2.15%
-212,100
1.3%
06/30/2018
Vanguard Total Stock Market Index Fund
4,355,252
2%
0
0%
07/31/2018
JPMorgan Funds - Global Healthcare Fund
4,161,536
1.92%
0
0.91%
05/31/2018
Fidelity Strategic Advisers Small Mid Cap Fund
3,810,909
1.76%
605,365
0.28%
02/28/2018
Fidelity Puritan Fund
3,536,926
1.63%
0
0.08%
07/31/2018
iShares Russell 2000 ETF
3,517,970
1.62%
-1,878
0.05%
09/06/2018
T Rowe Price Health Sciences Fund
3,451,099
1.59%
409,169
0.18%
06/30/2018
| Address |
6800 Broken Sound Parkway NW
Boca Raton Florida 33487
United States
|
|
Employees
|
- |
| Website |
http://www.therapeuticsmd.com |
| Updated |
07/08/2019 |
| TherapeuticsMD, Inc. operates as a healthcare company, which focuses on developing and commercializing products for women. Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The firm also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the vitaMedMD and BocaGreenMD brands. |
